share_log

SAB Biotherapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Sessa Capital (Master), L.P.

SEC announcement ·  Nov 15, 2023 16:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more